4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-070025
EVP, General Counsel, Corp Sec sold 3,750 shares at an average $11.18 ($41,939)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP, General Counsel, Corp Sec | 2026-11-02 | Sale 10b5-1 | −1,343 | $11.33 | $15,222 | 112,600 | D |
| de Verneuil Vanina EVP, General Counsel, Corp Sec | 2026-11-03 | Sale 10b5-1 | −2,407 | $11.10 | $26,718 | 110,193 | D |
| Open-market sales · 3,750 sh · avg $11.18 · $41,939 | |||||||
Loading xslF345X06/wk-form4_1793822169.xml…